Nexalin Enterprise Value Over E B I T D A from 2010 to 2025

NXLIW Stock  USD 0.20  0.22  52.38%   
Nexalin Technology Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA will likely drop to -0.4 in 2025. During the period from 2010 to 2025, Nexalin Technology Enterprise Value Over EBITDA regression line of quarterly data had mean square error of  6.62 and geometric mean of  4.98. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(0.38)
Current Value
(0.40)
Quarterly Volatility
4.95381741
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nexalin Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexalin Technology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 K, Interest Expense of 54.4 K or Selling General Administrative of 4 M, as well as many indicators such as Price To Sales Ratio of 29.38, Dividend Yield of 0.0 or PTB Ratio of 0.88. Nexalin financial statements analysis is a perfect complement when working with Nexalin Technology Valuation or Volatility modules.
  
Check out the analysis of Nexalin Technology Correlation against competitors.
For more information on how to buy Nexalin Stock please use our How to Invest in Nexalin Technology guide.

Latest Nexalin Technology's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Nexalin Technology over the last few years. It is Nexalin Technology's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexalin Technology's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Nexalin Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(8.09)
Geometric Mean4.98
Coefficient Of Variation(61.24)
Mean Deviation4.52
Median(11.70)
Standard Deviation4.95
Sample Variance24.54
Range11.324
R-Value0.86
Mean Square Error6.62
R-Squared0.75
Significance0.000015
Slope0.90
Total Sum of Squares368.10

Nexalin Enterprise Value Over E B I T D A History

2025 -0.4
2024 -0.38
2023 -0.42
2022 -3.3
2021 -2.76
2020 -5.12

About Nexalin Technology Financial Statements

Nexalin Technology investors use historical fundamental indicators, such as Nexalin Technology's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nexalin Technology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(0.38)(0.40)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nexalin Stock Analysis

When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.